carbamates and losartan potassium

carbamates has been researched along with losartan potassium in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Astley, JP; Davenport, A; Feest, TG; Goel, S; Jones, S	1
Golper, TA; Mun, KC	1
Brines, M; Dorsey, DA; Feng, D; Green, KG; Lee, JM; Parvin, CA; Schmidt, RE; Xiao, Q	1
Ankers, E; Berg, AH; Deferio, JJ; Kalim, S; Karumanchi, SA; Tamez, H; Thadhani, RI; Trottier, CA; Wenger, J	1
Amorim, RP; Araujo, MG; Carneiro, JE; Fernandes, MJ; Nehlig, A	1

Reviews

1 review(s) available for carbamates and losartan potassium

Article	Year
Neuroprotective agents and modulation of temporal lobe epilepsy. Frontiers in bioscience (Elite edition), 2015, 01-01, Volume: 7, Issue:1 Topics: Anticonvulsants; Carbamates; Epilepsy, Temporal Lobe; Erythropoietin; Humans; Neuroprotective Agents; Purinergic P1 Receptor Agonists	2015

Trials

1 trial(s) available for carbamates and losartan potassium

Article	Year
Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure. Kidney international, 1996, Volume: 50, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Carbamates; Diabetes Mellitus; Erythropoietin; Female; Hemoglobin A; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sex Factors; Uremia	1996

Article

Year

Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure.

Kidney international, 1996, Volume: 50, Issue:4

Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Carbamates; Diabetes Mellitus; Erythropoietin; Female; Hemoglobin A; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sex Factors; Uremia

1996

Other Studies

3 other study(ies) available for carbamates and losartan potassium

Article	Year
Impaired biological activity of erythropoietin by cyanate carbamylation. Blood purification, 2000, Volume: 18, Issue:1 Topics: Animals; Body Weight; Carbamates; Cyanates; Erythrocyte Count; Erythropoietin; Hematocrit; Hemoglobins; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride; Time Factors	2000
Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. Experimental neurology, 2008, Volume: 209, Issue:1 Topics: Animals; Carbamates; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythropoietin; Ganglia, Sympathetic; Immunohistochemistry; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neurites; Receptors, Erythropoietin; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2008
Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease. Clinical journal of the American Society of Nephrology : CJASN, 2013, Volume: 8, Issue:11 Topics: Aged; Aged, 80 and over; Anemia; Biomarkers; Carbamates; Drug Resistance; Erythropoietin; Female; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prospective Studies; Protein Processing, Post-Translational; Renal Dialysis; Risk Factors; Serum Albumin; Serum Albumin, Human; Time Factors; United States	2013